» Articles » PMID: 34431684

Use of Saliva Swab for Detection of Influenza Virus in Patients Admitted to an Emergency Department

Overview
Specialty Microbiology
Date 2021 Aug 25
PMID 34431684
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Nasopharyngeal (NP) specimens are commonly used for the detection of influenza, but saliva swabs are easier to obtain and cause less discomfort to the patients. The objective of this study was to evaluate the usefulness of saliva swab specimens for the diagnosis of influenza compared with NP specimens. Influenza virus detection rate in saliva and NP swabs was compared in adult patients admitted to an emergency department from January to March 2020, using the Xpert Xpress Flu/respiratory syncytial virus (RSV) test. Cycle threshold () values were evaluated in all the cases. Among the 82 patients recruited, 19 had an influenza-positive diagnostic test result (11 influenza A and 8 influenza B). Overall, the agreement between saliva and NP swabs results was 97.6% (80/82; κ = 0.929; 95% confidence interval [CI], 0.832 to 1.0). There was no significant difference in the influenza detection rate between saliva swab and NP specimens (20.7% [17/82] versus 23.2% [19/82];  = 0.5). There were only two discordant results (influenza B in an NP and false negative in a saliva sample). Manual inspection of the amplification curves showed that influenza RNA had been amplified in saliva with high s ( of 40) that the test reported as a negative result. The overall sensitivity and specificity for saliva was 89.5% (73.0% to 100%) and 100% (99.2% to 100%), respectively. In all the cases, the same influenza virus (A/B) was detected. Median values were significantly lower in NP (31; interquartile range [IQR], 21.0 to 32.0) than in saliva (33; IQR, 23.0 to 38.0) ( = 0.001) specimens. Saliva swabs have high sensitivity and specificity for the detection of influenza virus by the Xpert Xpress Flu/RSV test and a high overall agreement and correlation with NP specimens. Saliva swab is a feasible specimen type for influenza testing that might be easily self-collected with minimal equipment and discomfort. Early detection of influenza virus is important for guiding antiviral and antibacterial treatment for infection control and public health measures. We have observed that saliva swab specimens have high sensitivity and specificity for the detection of influenza by the Xpert Xpress Flu/respiratory syncytial virus (RSV) test and high overall agreement and correlation with nasopharyngeal specimens. Saliva swab may therefore be a feasible specimen type for influenza testing that can be easily self-collected with minimal equipment and discomfort.

Citing Articles

Exploring the pathway toward the reduction of paediatric seasonal influenza burden: school-based vaccination and surveillance.

Gori M, Fappani C, Bianchi S, Tanzi E, Zuccotti G, Amendola A J Prev Med Hyg. 2025; 65(4):E469-E472.

PMID: 40026430 PMC: 11870125. DOI: 10.15167/2421-4248/jpmh2024.65.4.3190.


Debulking influenza and herpes simplex virus strains by a wide-spectrum anti-viral protein formulated in clinical grade chewing gum.

Daniell H, Guo Y, Singh R, Karki U, Kulchar R, Wakade G Mol Ther. 2024; 33(1):184-200.

PMID: 39663701 PMC: 11764783. DOI: 10.1016/j.ymthe.2024.12.008.


A one-step low-cost molecular test for SARS-CoV-2 detection suitable for community testing using minimally processed saliva.

da Silva S, Amaral C, Malta-Luis C, Grilo D, Duarte A, Morais I Biol Methods Protoc. 2024; 9(1):bpae035.

PMID: 38835855 PMC: 11147803. DOI: 10.1093/biomethods/bpae035.


Seasonal influenza viruses decay more rapidly at intermediate humidity in droplets containing saliva compared to respiratory mucus.

Rockey N, Le Sage V, Marr L, Lakdawala S Appl Environ Microbiol. 2024; 90(2):e0201023.

PMID: 38193683 PMC: 10880610. DOI: 10.1128/aem.02010-23.


Influenza A, like Omicron SARS-CoV-2, Is Similarly Detected in Saliva or Nasopharyngeal Samples via RT-qPCR.

Abreu H, Royer C, Poitevin C, Kohler A, Rodrigues A, Raboni S Viruses. 2023; 15(12).

PMID: 38140593 PMC: 10747790. DOI: 10.3390/v15122352.


References
1.
Suda Y, Nagatomo M, Yokoyama R, Ohzono M, Aoyama K, Zhang X . Highly sensitive detection of influenza virus in saliva by real-time PCR method using sugar chain-immobilized gold nanoparticles; application to clinical studies. Biotechnol Rep (Amst). 2017; 7:64-71. PMC: 5466045. DOI: 10.1016/j.btre.2015.05.004. View

2.
To K, Yip C, Lai C, Wong C, Ho D, Pang P . Saliva as a diagnostic specimen for testing respiratory virus by a point-of-care molecular assay: a diagnostic validity study. Clin Microbiol Infect. 2018; 25(3):372-378. DOI: 10.1016/j.cmi.2018.06.009. View

3.
Sueki A, Matsuda K, Yamaguchi A, Uehara M, Sugano M, Uehara T . Evaluation of saliva as diagnostic materials for influenza virus infection by PCR-based assays. Clin Chim Acta. 2015; 453:71-4. DOI: 10.1016/j.cca.2015.12.006. View

4.
Hanson K, Barker A, Hillyard D, Gilmore N, Barrett J, Orlandi R . Self-Collected Anterior Nasal and Saliva Specimens versus Health Care Worker-Collected Nasopharyngeal Swabs for the Molecular Detection of SARS-CoV-2. J Clin Microbiol. 2020; 58(11). PMC: 7587122. DOI: 10.1128/JCM.01824-20. View

5.
Lopez Roa P, Rodriguez-Sanchez B, Catalan P, Giannella M, Alcala L, Padilla B . Diagnosis of influenza in intensive care units: lower respiratory tract samples are better than nose-throat swabs. Am J Respir Crit Care Med. 2012; 186(9):929-30. DOI: 10.1164/ajrccm.186.9.929. View